Anika Therapeutics Inc (ANIK)
NASDAQ
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-06-03 | Mr. Stephen D. GriffinPresident, Principal Financial Officer, CEO & Director | -3.77k | 54.31k | Derivative Exercise and Sale | 14.41 | 45.97k | - |
| 2026-06-03 | Mr. Stephen D. GriffinPresident, Principal Financial Officer, CEO & Director | 9.07k | 0.00 | Derivative Exercise and Retained Stock | - | 45.97k | 24.58% |
| 2026-05-01 | Mr. John B. HennemanLead Independent Director | 5.00k | 73.32k | 買い | 14.66 | 54.87k | 10.03% |
| 2026-04-30 | Mr. Stephen D. GriffinPresident, Principal Financial Officer, CEO & Director | 12.20k | 149.88k | 買い | 12.29 | 36.16k | 50.91% |
| 2026-03-15 | Mr. David Colleranインサイダー | -1.89k | 26.88k | Derivative Exercise and Sale | 14.20 | 67.57k | - |
| 2026-03-14 | Mr. David Colleranインサイダー | 13.94k | 0.00 | Derivative Exercise and Retained Stock | - | 67.57k | 26.00% |
| 2026-03-14 | Mr. David Colleranインサイダー | -4.17k | 59.19k | Sale to Issuer | 14.20 | 67.57k | -5.81% |
| 2026-03-14 | Mr. Stephen D. GriffinPresident, Principal Financial Officer, CEO & Director | -5.94k | 84.40k | Sale to Issuer | 14.20 | 23.96k | -19.87% |
| 2026-03-14 | Mr. Stephen D. GriffinPresident, Principal Financial Officer, CEO & Director | 12.82k | 0.00 | Derivative Exercise and Retained Stock | - | 23.96k | 115.13% |
| 2026-03-14 | Dr. Cheryl Renee BlanchardExecutive Chair | 37.55k | 0.00 | Derivative Exercise and Retained Stock | - | 270.53k | 16.12% |
| 2026-03-14 | Dr. Cheryl Renee BlanchardExecutive Chair | -14.73k | 209.14k | Sale to Issuer | 14.20 | 270.53k | -5.16% |
| 2026-03-15 | Dr. Cheryl Renee BlanchardExecutive Chair | -12.10k | 171.88k | Derivative Exercise and Sale | 14.20 | 270.53k | - |
| 2026-03-15 | Mr. Ian W. McLeodSenior VP, CAO & Treasurer | -781.00 | 11.09k | Derivative Exercise and Sale | 14.20 | 24.11k | - |
| 2026-03-14 | Mr. Ian W. McLeodSenior VP, CAO & Treasurer | 5.65k | 0.00 | Derivative Exercise and Retained Stock | - | 24.11k | 30.62% |
| 2026-03-14 | Mr. Ian W. McLeodSenior VP, CAO & Treasurer | -1.45k | 20.58k | Sale to Issuer | 14.20 | 24.11k | -5.67% |
| 2026-03-09 | Dr. Cheryl Renee BlanchardExecutive Chair | 14.13k | 0.00 | Derivative Exercise and Retained Stock | - | 223.19k | 6.76% |
| 2026-03-09 | Dr. Cheryl Renee BlanchardExecutive Chair | -5.87k | 87.83k | Derivative Exercise and Sale | 14.96 | 223.19k | - |
| 2026-03-09 | Mr. David Colleranインサイダー | -1.92k | 28.71k | Derivative Exercise and Sale | 14.96 | 53.10k | - |
| 2026-03-09 | Mr. David Colleranインサイダー | 3.55k | 0.00 | Derivative Exercise and Retained Stock | - | 53.10k | 7.16% |
| 2026-03-09 | Mr. Ian W. McLeodSenior VP, CAO & Treasurer | -639.00 | 9.56k | Derivative Exercise and Sale | 14.96 | 18.74k | - |
| 2026-03-09 | Mr. Ian W. McLeodSenior VP, CAO & Treasurer | 1.56k | 0.00 | Derivative Exercise and Retained Stock | - | 18.74k | 9.07% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。